CLC Number:
[1] Yadav RS, Jayswal A, Shrestha S, et al. Dystrophic epidermolysis bullosa[J]. JNMA J Nepal Med Assoc, 2018, 56(213): 879-882. [2] Kim M, Li M, Intong-Wheeler LRA, et al. Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand[J]. Acta Derm Venereol, 2018, 98(1): 70-76. [3] Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification[J]. J Am Acad Dermatol, 2014, 70(6): 1103-1126. [4] Siprashvili Z, Nguyen NT, Gorell ES, et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa[J]. JAMA, 2016, 316(17): 1808-1817. [5] Yenamandra VK, Vellarikkal SK, Chowdhury MR, et al. Genotype-phenotype correlations of dystrophic epidermolysis bullosa in India: experience from a tertiary care centre[J]. Acta Derm Venereol, 2018, 98(9): 873-879. [6] Solis D, Nazaroff J, Dutt-Singkh Y, et al. 572 defining chronic wound types in recessive dystrophic epidermolysis bullosa patients for clinical outcome assessment[J]. J Invest Dermatol, 2018, 138(5): S97. [7] Gorell ES, Nguyen N, Siprashvili Z, et al. Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy[J]. Br J Dermatol, 2015, 173(3): 821-823. [8] Danial C, Adeduntan R, Gorell ES, et al. Prevalence and characterization of pruritus in epidermolysis bullosa[J]. Pediatr Dermatol, 2015, 32(1): 53-59. [9] Arslan E, Çermik TF, Koku Aksu AE, et al. Detection of squamous cell carcinoma foci in a patient with dystrophic epidermolysis bullosa in 18F-FDG PET/CT[J]. Mol Imaging Radionucl Ther, 2019, 28(2): 79-82. [10] Graham T, Sooriah S, Giampieri S, et al. Iterative codesign and testing of a novel dressing glove for epidermolysis bullosa[J]. J Wound Care, 2019, 28(1): 5-14. [11] Eichstadt S, Barriga M, Ponakala A, et al. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa[J]. JCI Insight, 2019, 4(19):e130554. doi: 10.1172/jci.insight.130554. [12] Vanden Oever M, Twaroski K, Osborn MJ, et al. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa[J]. Pediatr Res, 2018, 83(1-2): 318-324. |
[1] | SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury [J]. Journal of Shandong University (Health Sciences), 2020, 58(7): 1-6. |
[2] | ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice [J]. Journal of Shandong University (Health Sciences), 2020, 58(7): 7-14. |
[3] | SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2020, 58(7): 47-52. |
[4] | JI Yongjuan, XIANG Zini, KUANG Guifang. A path analysis on the influence of burnout on quality of life among staff in two tertiary hospitals in Qingdao [J]. Journal of Shandong University (Health Sciences), 2020, 58(7): 102-107. |
[5] | ZHANG Wei, TAN Wenhao, LI Yibin. Locmotion control of quadruped robot based on deep reinforcement learning: review and prospect [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 61-66. |
[6] | WU Qiang, HE Zekun, LIU Ju, CUI Xiaomeng, SUN Shuang, SHI Wei. A research on multi-modal MRI analysis based on machine learning for brain glioma [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 81-87. |
[7] | YIN Yilong, XI Xiaoming, MENG Xianjing. Intelligent diagnosis methods of Alzheimers disease [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 14-21. |
[8] | LIU Ju, WU Qiang, YU Luyue, LIN Fengming. Brain tumor image segmentation based on deep learning techniques [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 42-49. |
|